ProBioGen appoints Dr Simon Johannes Bulling as its new Chief Operating Officer
Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations
Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations
Valneva will consolidate its French operations at its Lyon site and close its Nantes location
This predictive technology empowers people with diabetes to take preventive action before complications arise
The survey revealed that the proportion of individuals experiencing constant thoughts about food throughout the day declined by 46 percent after starting Wegovy
Cagrilintide represents a novel approach to obesity management
Collaboration reinforces Boehringer Ingelheim’s expertise in microbial contract development and manufacturing
Data highlight ambition to transform prevention and treatment for serious bacterial infections and develop novel preventative strategies for respiratory viral infections
New trontinemab data continue to support rapid and deep, dose-dependent reduction of amyloid plaques in Phase Ib/IIa Brainshuttle AD study
Findings to form the basis for a Phase 3 program, anticipated to start in H2 2025
Subscribe To Our Newsletter & Stay Updated